Abstract
Background
Varicella-zoster virus infection is associated with significant morbidity and mortality in immune-compromised children, despite treatment with antiviral agents. Universal varicella vaccine programs have significantly decreased this risk in many highincome countries, but in most low-income and middleincome countries, the burden of varicella in children treated for malignancy is poorly defined.
Methods
We retrospectively reviewed records of children at the National Unit of Pediatric Oncology (UNOP) in Guatemala diagnosed with varicella between January 2009 and March 2013 in order to calculate incidence of varicella and evaluate morbidity, mortality, treatment interruption, and cost.
Results
Fifty-nine cases of varicella were identified. Incidence was 23.4 cases per 1000 person-years (p-y). 66.1% of cases occurred in children with leukemia (median age 5.2 years; interquantile range 3.4-7 years) and 41.0% of these occurred during maintenance therapy. Source of exposure was identified for 14/59 (23.7%) children. Most were hospitalized (71.2%) and given intravenous acyclovir (64.4%). Eight (13.6%) children required critical care, and two (3.4%) died from disseminated varicella with multiorgan failure. Chemotherapy was delayed or omitted due to varicella in 50%. No significant differences in outcomes based on nutritional and immunologic status were detected. The minimum average cost of treatment per episode was 598.75 USD.
Conclusions
Varicella is a significant problem in children treated for cancer in Guatemala, where effective post-exposure prophylaxis is limited. In the absence of universal varicella vaccination, strategies to improve recognition of exposure and the future use of novel inactivated vaccines currently under investigation in clinical trials could mitigate this burden.
Article PDF
Similar content being viewed by others
References
Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012;380:2095–2128.
Gupta S, Antillon FA, Bonilla M, Fu L, Howard SC, Ribeiro RC, et al. Treatment-related mortality in children with acute lymphoblastic leukemia in Central America. Cancer 2011;117:4788–4795.
Gupta S, Bonilla M, Valverde P, Fu L, Howard SC, Ribeiro RC, et al. Treatment-related mortality in children with acute myeloid leukaemia in Central American: incidence, timing and predictors. Eur J Cancer 2012;48:1363–1369.
Aziz Z, Zahid M, Mahmood R, Maqbool S. Modified BFM protocol for childhood acute lymphoblastic leukemia: a retrospective analysis. Med Pediatr Oncol 1997;28:48–53.
Advani S, Pai S, Venzon D, Adde M, Kurkure PK, Nair CN, et al. Acute lymphoblastic leukemia in India: an analysis of prognostic factors using a single treatment regimen. Ann Oncol 1999;10:167–176.
Laosombat V, Wongchanchailert M, Sattayasevana B, Wiriyasateinkul A, Watana-Arepornchai S. The treatment of children with acute lymphoblastic leukemia in Thailand. Med Pediatr Oncol 2002;38:266–268.
Howard SC, Pedrosa M, Lins M, Pedrosa A, Pui CH, Ribeiro RC, et al. Establishment of a pediatric oncology program and outcomes of childhood acute lymphoblastic leukemia in a resource-poor area. JAMA 2004;291:2471–2475.
Metzger ML, Howard SC, Fu LC, Peña A, Stefan R, Hancock ML, et al. Outcomes of childhood acute lymphoblastic leukemia in resource-poor countries. Lancet 2003;362:706–708.
Feldman S, Lott L. Varicella in children with cancer: impact of antiviral therapy and prophylaxis. Pediatrics 1987;80:465–472.
American Academy of Pediatrics. Varicella-zoster infections. In: Pickering LK, Baker CJ, Long S, McMillan JA, eds. Red Book Online: 2012 Report of the Committee on Infectious Diseases, 29th edition. Available at: http://aapredbook.aappublications.org/content/current (accessed September 21, 2014).
Buda K, Tubergen DG, Levin M. The frequency and consequences of varicella exposure and varicella infection in children receiving maintenance therapy for acute lymphoblastic leukemia. J Pediatr Hematol Oncol 1996;18:106–112.
Nyerges G, Meszner Z, Gyarmati E, Kerpel-Fronius S. Acyclovir prevents dissemination of varicella in immunocompromised children. J Infect Dis 1988;157:309.
Shah SS, Wood SM, Luan X, Ratner AJ. Decline in varicellarelated ambulatory visits and hospitalizations in the United States since routine immunization against varicella. Ped Infect Dis J 2010;29:199–204.
Marin M, Zhang JX, Seward JF. Near elimination of varicella deaths in the US after implementation of the vaccination program. Pediatrics 2011;128:214–220.
Adler AL, Casper C, Boeckh M, Heath J, Zerr DM. An outbreak of varicella with likely breakthrough disease in a population of pediatric cancer patients. Infect Control Hosp Epidemiol 2008;29:866–870.
Paternina-Caicedo A, De la Hoz-Restrepo F, Gamboa-Garay O, Castañeda-Orjuela C, Velandia-González M, Alvis-Guzmán N. How cost effective is universal varicella vaccination in developing countries? A case-study from Colombia. Vaccine 2013;31:402–409.
De Pernillo M, Rivas S, Fuentes L, Antillón F, Barr RD. Measurement of socio-economic status in families of children with cancer in Guatemala. Pediatr Blood Cancer 2014;61:2071–2073.
Antillón F, Rossi E, Molina AL, Sala A, Pencharz P, Valsecchi MG, Barr R. Nutritional status of children during treatment for acute lymphoblastic leukemia in Guatemala. Pediatr Blood Cancer 2013;60:911–915.
Quintana Y, Patel AN, Naidu PE, Howard SC, Antillon FA, Ribeiro RC. POND4Kids: a web-based pediatric cancer database for hospital-based cancer registration and clinical collaboration. Stud Health Technol Inform 2011;164:227–231.
Harris PA. Research electronic data capture (REDCap)–planning, collecting and managing data for clinical and translational research. BMC Bioinformatics 2012;13:A15.
World Health Organization. WHO SAS macro package, 2007. http://www.who.int/growthref/tools/readme_sas.pdf (accessed August 3, 2013).
R Development Core Team. R: A language and environment for statistical computing. Version 2. 15. 3. http://www.Rproject.org/ (accessed August 3, 2013).
Bardach A, Cafferata ML, Klein K, Cormick G, Gibbons L, Ruvinsky S. Incidence and use of resources for chickenpox and herpes zoster in Latin America and the Caribbean–A systematic review and meta-analysis. Pediatr Infectious Dis J 2012;31:1263–1268.
Folatre I, Zolezzi P, Schmidt D, Marín F, Täger M. Infections caused by Varicella Zoster virus in children with cancer aged less than 15 years old. Rev Med Chil 2003;131:759–764. [In Spanish]
Bhatia S, Landier W, Shangguan M, Hageman L, Schaible AN, Carter AR, et al. Nonadherence to oral mercaptopurine and risk of relapse in Hispanic and non-Hispanic white children with acute lymphoblastic leukemia: a report from the Children’s Oncology Group. J Clin Oncol 2012;30:2094–2101.
Guris D, Jumaan AO, Mascola L, Watson BM, Zhang JX, Chaves SS, et al. Changing varicella epidemiology in active surveillance sites–United States, 1995-2005. J Infect Dis 2008;197:S71–S75.
Bialek SR, Perella D, Zhang J, Mascola L, Viner K, Jackson C, et al. Impact of a routine two-dose varicella vaccination program on varicella epidemiology. Pediatrics 2013;132:e1134–e1140.
Wharton M. The epidemiology of varicella-zoster virus infections. Inf Dis Clinics North America 1996;10:571–581.
Joint Committee on Vaccination and Immunisation. Statement on varicella and herpes zoster vaccines. Available from: http://webarchive.nationalarchives.gov.uk/20120907090205/http:/www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/@dh/@ab/documents/digitalasset/dh_133599. pdf (accessed March 12, 2014).
Macartney K, McIntyre P. Vaccines for post-exposure prophylaxis against varicella (chickenpox) in children and adults. Cochrane Database Syst Rev 2008;(3):CD001833.
Levin MJ. Varicella vaccination of immunocompromised children. J Infect Dis 2008;197:S200–S206.
Marin M, Güris D, Chaves SS, Schmid S, Seward JF; Advisory Committee on Immunization Practices, Centers for Disease Control and Prevention (CDC). Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2007;56:1–40.
Mullane KM, Winston DJ, Wertheim MS, Betts RF, Poretz DM, Camacho LH, et al. Safety and immunogenicity of heat-treated zoster vaccine (ZVHT) in immunocompromised adults. J Infect Dis 2013;208:1375–1385.
Leroux-Roels I, Leroux-Roels G, Clement F, Vandepapelière P, Vassilev V, Ledent E, et al. A phase I/II clinical trial evaluating safety and immunogenicity of a varicella zoster glycoprotein E subunit vaccine candidate in young and older adults. J Infect Dis 2012;206:1280–1290.
Ishida Y, Tauchi H, Higaki A, Yokota-Outou Y, Kida K. Postexposure prophylaxis of varicella in children with leukemia by oral acyclovir. Pediatrics 1996;97:150.
Asano Y, Yoshikawa T, Suga S, Kobayashi I, Nakashima T, Yazaki T, et al. Postexposure prophylaxis of varicella in family contact by oral acyclovir. Pediatrics 1993;92:219–222.
Suga S, Yoshikawa T, Ozaki T, Asano Y. Effect of oral acyclovir against primary and secondary viraemia in incubation period of varicella. Arch Dis Child 1993;69:639–642.
Shinjoh M, Takahashi T. Varicella zoster exposure on paediatric wards between 2000 and 2007: safe and effective postexposure prophylaxis with oral aciclovir. J Hosp Infec 2009;72:163–168.
Fisher JPH, Bate J, Hambleton S. Preventing varicella in children with malignancies: what is the evidence? Curr Opin Infect Dis 2011;24:203–211.
Bate J, Chisholm J, Heath PT, Breuer J, Skinner R, Manley S, et al. PEPtalk: postexposure prophylaxis against varicella in children with cancer. Arch Dis Child 2011;96:841–845.
Levin MJ, Rotbart HA, Hayward AR. Immune response to varicella-zoster five years after acyclovir therapy of childhood varicella. J Infect Dis 1995;171:1383–1384.
Weinberg A, Levin MJ. VZV T cell-mediated immunity. In: Arvin A, Abendroth A, eds. Varicella-zoster virus: current topics in microbiology and immunology. Berlin: Springer Verlag, 2010: 341–358.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Brown, A.E.C., Asturias, E.J., Melgar, M. et al. Incidence and consequences of varicella in children treated for cancer in Guatemala. World J Pediatr 12, 320–326 (2016). https://doi.org/10.1007/s12519-016-0025-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12519-016-0025-y